← All stories
Markets
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
AUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have alre…
Covered by 1 outlet
All coverage · 1 article